Orhthobiologics Market Global Industry Analysis, Future Insights, Top Leaders and Forecast to 2024

Market Overview:

According to a leading research firm - Market Research Future (MRFR), the global Orthobiologics Market is projected to reach USD 4,964 MN by the end of 2019. MRFR, in its recently publishes study report, also asserts that the market would register around 5.6% CAGR during the forecast period (2019–2024).

Orthobiologics materials are made from substances naturally found in the human body. Usages of these substances help to cure injuries rapidly. Hence orthobiologics are extensively used in surgeries and treatments of osteoarthritis & degenerative arthritis, spinal fusion, fracture recovery, soft tissue injuries, and to treat other bone-related injuries such as the broken bones along with injured muscles, tendons, and ligaments.

Access Full Report Details and TOC With PDF Illustration Exclusively @ https://www.marketresearchfuture.com/reports/orthobiologics-market-7826

Major Player:

• Exactech
• Arthrex
• Globus Medical Inc
• Johnson & Johnson
• Integra LifeSciences
• Medline Industries
• Stryker Corporation
• NuVasive
• Wright Medical Group NV
• Zimmer Biomet

Competitive Landscape:

Highly competitive, the orthobiologics market appears to be fragmented due to the presence of several well-established players. Moreover, the market attracts several new entrants, demonstrating attractive growth opportunities. This, as a result, intensifies the competition in the market, further. Manufacturers strive to develop innovative materials, utilizing advanced technologies and best practices.

To gain a substantial share in the market, players incorporate strategies such as mergers & acquisitions, collaboration, and expansion. They make substantial investments in R&D for product development and improvements. Expansions and superior product development help them in increasing sales, production capacities, and potential to fetch larger turnovers at a much-reduced logistic cost.

Segmentation:

The market is segmented into four dynamics to widen the scope of understanding,

By Product: Demineralized Bone Matrix (DBM), Bone Morphogenetic Protein (BPM), Allograft, Viscosupplementation Products, Synthetic Bone Substitutes, and others.

By Application: Osteoarthritis & Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries, and others.

By End-user: Hospitals, Orthopedic Clinics, and others.

By Regions: Europe, North America, APAC, and the Rest-of-the-World (RoW)

Geographical Analysis:

North America dominates the global orthobiologics market, owing to the technological advancements, increasing funding & investments, and rising prevalence of bone injuries caused due to accidents. Heading with favorable government regulations that are growing integration for orthobiologics, the region is would retain its leading position throughout the assessment period.

Simultaneously, rising numbers of orthopedic surgeries, alongside, the increasing geriatric populace, boost the growth of the regional market, leading to an increase in the patient population. Furthermore, increasing awareness among people and the rising demand for technologically advanced treatments and products enhances the growth of the regional market.

Europe stands second in the global orthobiologics market. Factors such as the increased research & development activities in the field backed by government support and funds, attribute to the regional market growth. The availability of innovative treatment facilities alongside, the rising research initiatives in the field of orthopedic biomaterials is fostering the market growth in the region. Moreover, increasing orthopedic surgeries with growing awareness among populations regarding healthcare.

Industry/ Innovation /Related News:

September 25, 2019 --- Bioventus LLC (the US), a global leader in the science & application of orthobiologics, announced signing a nationwide contract with UnitedHealthcare Employer (UHC – the US), a healthcare insurance company to provide them with the access to its DUROLANE and GELSYN-3 treatments for osteoarthritis (OA) knee pain. These products promote healing in the treatment of osteoarthritis and surgical and non-surgical bone healing.

October 1, 2019, UHC commercial plan members will have access to these safe HA products, proven to provide relief from knee OA pain management. This includes the production and marketing of ultrasound bone growth stimulators.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Contact: Market Research Future +1 646 845 9312 Email: sales@marketresearchfuture.com